NCT05592535

Brief Summary

The use of fractional flow reserve (FFR) to assess the functional relevance of coronary stenoses has been demonstrated to reduce the risk urgent revascularization in chronic coronary syndrome patients.\[1\] The goal of this study is to assess whether the utility of using FFR during percutaneous coronary intervention (PCI) in chronic coronary syndrome patients is confirmed in a real-life scenario. This study will implement a regression discontinuity design (RDD). RDD is a quasi-experimental study design able to provide robust findings on causality using observational data.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2015

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

October 17, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 24, 2022

Completed
Last Updated

October 24, 2022

Status Verified

October 1, 2022

Enrollment Period

5 years

First QC Date

October 17, 2022

Last Update Submit

October 20, 2022

Conditions

Keywords

Percutaneous Coronary InterventionFractional Flow Reserve

Outcome Measures

Primary Outcomes (1)

  • Risk difference (%) for the composite of all-cause death and FFR-oriented target vessel revascularization by PCI

    Up to one year following index FFR measurement

Secondary Outcomes (3)

  • Risk difference (%) for the composite of all-cause death, FFR-oriented target vessel revascularization by PCI and hospitalization for acute myocardial infarction

    Up to one year following index FFR measurement

  • Risk difference (%) for the composite of all-cause death and new hospitalization for acute myocardial infarction

    Up to one year following index FFR measurement

  • Risk differences (%) for the individual components of the composite outcome measures

    Up to one year following index FFR measurement

Study Arms (2)

FFR below 0.80

Patients with significant coronary hyperemic gradient

Procedure: Coronary revascularization

FFR above 0.80

Patients without significant coronary hyperemic gradient

Interventions

Coronary revascularization performed by PCI in a vessel investigated with FFR or indication for surgery

FFR below 0.80

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with chronic coronary syndrome undergoing coronary angiography and FFR measurement in Sweden.

You may qualify if:

  • Chronic coronary syndrome undergoing coronary angiography and FFR measurement
  • Swedish personal identification number

You may not qualify if:

  • previous coronary artery bypass grafting
  • left main disease or undergoing FFR/PCI of left main
  • IVUS/OCT use
  • diffuse disease (≥ 2 segments treated in a same vessel investigated with FFR, ≥ 2 segments investigated with FFR in a same vessel)
  • PCI in a distal segment with respect to FFR measurements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Mobius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engstrom T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Juni P, Fearon WF; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012 Sep 13;367(11):991-1001. doi: 10.1056/NEJMoa1205361. Epub 2012 Aug 27.

    PMID: 22924638BACKGROUND
  • Jernberg T, Attebring MF, Hambraeus K, Ivert T, James S, Jeppsson A, Lagerqvist B, Lindahl B, Stenestrand U, Wallentin L. The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart. 2010 Oct;96(20):1617-21. doi: 10.1136/hrt.2010.198804. Epub 2010 Aug 27.

    PMID: 20801780BACKGROUND
  • Calonico S, Cattaneo MD, Farrell MH. Optimal bandwidth choice for robust bias corrected inference in regression discontinuity designs. Econom J. 2020;23(2):192-210.

    BACKGROUND
  • Calonico S, Cattaneo MD, Titiunik R. Robust nonparametric confidence intervals for regression-discontinuity designs. Econometrica. 2014;82(6):2295-2326.

    BACKGROUND

MeSH Terms

Interventions

Percutaneous Coronary Intervention

Intervention Hierarchy (Ancestors)

Endovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2022

First Posted

October 24, 2022

Study Start

June 1, 2015

Primary Completion

June 1, 2020

Study Completion

June 1, 2020

Last Updated

October 24, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share